RNF213 Peptide | 46-305P

RNF213 Peptide | 46-305P | Gentaur UK, US & Europe Distribution

Short Description: (IN) RNF213 / C17orf27 Peptide

Species: N/A

Location: RNF213 peptide corresponds to 14 amino acids near the intermediate domain of RNF213.

Tested Application: Bl

Application: RNF213 Peptide is used for blocking the activity of RNF213 antibody (catalog number 46-305). The RNF213 antibody ships at 0.5 mg/mL and the RNF213 Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

Physical State: Lyophilized

Buffer: RNF213 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

Concentration: N/A

Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.

NCBI Official Symbol: RNF213

Alternate Names: ALO17, MYMY2, MYSTR, NET57, C17orf27, KIAA1618, ALO17, KIAA1554, E3 ubiquitin-protein ligase RNF213, ALK lymphoma oligomerization partner on chromosome 17,

NCBI Gene ID: 57674

User Note: N/A

NCBI Official Name: Ring Finger Protein 213

Background: N/A

Disclaimer: This product is for research use only.